Cell Reports Resource The Major Risk Factors for Alzheimer ’ s Disease : Age , Sex , and Genes Modulate the Microglia Response to A b Plaques

[1]  Emily Merrill,et al.  Novel methods for integration and visualization of genomics and genetics data in Alzheimer's disease , 2019, Alzheimer's & Dementia.

[2]  Evan Z. Macosko,et al.  Single‐Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell‐State Changes , 2019, Immunity.

[3]  F. Edwards,et al.  Genetic variability in response to Aβ deposition influences Alzheimer’s risk , 2018 .

[4]  H. Weiner,et al.  Microglial signatures and their role in health and disease , 2018, Nature Reviews Neuroscience.

[5]  Benjamin A. Logsdon,et al.  The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease , 2018, Scientific Data.

[6]  Michelle K. Lupton,et al.  A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease , 2018, Molecular Psychiatry.

[7]  S. Makin.  The amyloid hypothesis on trial , 2018, Nature.

[8]  E. Marcello,et al.  Sex-Specific Features of Microglia from Adult Mice , 2018, Cell reports.

[9]  Charles C. White,et al.  A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer’s disease , 2018, Nature Neuroscience.

[10]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[11]  D. Holtzman,et al.  ApoE facilitates the microglial response to amyloid plaque pathology , 2018, The Journal of experimental medicine.

[12]  B. Becher,et al.  High‐Dimensional Single‐Cell Mapping of Central Nervous System Immune Cells Reveals Distinct Myeloid Subsets in Health, Aging, and Disease , 2018, Immunity.

[13]  Melanie A. Huntley,et al.  Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer's Disease Not Evident in Mouse Models. , 2018, Cell reports.

[14]  R. Marioni,et al.  GWAS on family history of Alzheimer’s disease , 2018, bioRxiv.

[15]  David A. Knowles,et al.  Inferring relevant cell types for complex traits using single-cell gene expression , 2017, bioRxiv.

[16]  C. Behl,et al.  Beyond Amyloid – Widening the View on Alzheimer's Disease , 2017, Journal of neurochemistry.

[17]  A. Regev,et al.  Temporal Tracking of Microglia Activation in Neurodegeneration at Single-Cell Resolution , 2017, Cell reports.

[18]  Markus Glatzel,et al.  The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. , 2017, Immunity.

[19]  Hannah A. Pliner,et al.  Reversed graph embedding resolves complex single-cell trajectories , 2017, Nature Methods.

[20]  B. Winblad,et al.  APP mouse models for Alzheimer's disease preclinical studies , 2017, The EMBO journal.

[21]  I. Amit,et al.  A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.

[22]  Amaia M. Arranz,et al.  PLD3 gene and processing of APP , 2017, Nature.

[23]  Kevin W. Eliceiri,et al.  ImageJ2: ImageJ for the next generation of scientific image data , 2017, BMC Bioinformatics.

[24]  O. Garaschuk,et al.  Coupled Proliferation and Apoptosis Maintain the Rapid Turnover of Microglia in the Adult Brain , 2017, Cell reports.

[25]  Andrew J. Hill,et al.  Single-cell mRNA quantification and differential analysis with Census , 2017, Nature Methods.

[26]  S. Itohara,et al.  Cognitive deficits in single App knock-in mouse models , 2016, Neurobiology of Learning and Memory.

[27]  James A. Eddy,et al.  Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases , 2016, Scientific Data.

[28]  R. Ransohoff.  A polarizing question: do M1 and M2 microglia exist? , 2016, Nature Neuroscience.

[29]  Lino C. Gonzalez,et al.  TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia , 2016, Neuron.

[30]  Benjamin E. L. Lauffer,et al.  Untangling the brain's neuroinflammatory and neurodegenerative transcriptional responses , 2016, Nature Communications.

[31]  C. Mazure,et al.  Sex differences in Alzheimer's disease and other dementias , 2016, The Lancet Neurology.

[32]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[33]  Eric Karran,et al.  The Cellular Phase of Alzheimer’s Disease , 2016, Cell.

[34]  Neil Buckholtz,et al.  Accelerating Medicines Partnership: Alzheimer’s Disease (AMP-AD) Knowledge Portal Aids Alzheimer’s Drug Discovery through Open Data Sharing , 2016, Expert opinion on therapeutic targets.

[35]  J. Hardy,et al.  Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease , 2016, Current Opinion in Neurobiology.

[36]  M. Owen,et al.  Alzheimer's disease: The amyloid hypothesis on trial , 2016, British Journal of Psychiatry.

[37]  Tom Michoel,et al.  Microglial brain region-dependent diversity and selective regional sensitivities to ageing , 2015, Nature Neuroscience.

[38]  Karl Herrup,et al.  The case for rejecting the amyloid cascade hypothesis , 2015, Nature Neuroscience.

[39]  A. Goate,et al.  Cruchaga & Goate reply , 2015, Nature.

[40]  M. Nöthen,et al.  PLD3 and sporadic Alzheimer's disease risk , 2015, Nature.

[41]  A. Goate,et al.  Cruchaga & Goate reply , 2015, Nature.

[42]  M. Nöthen,et al.  PLD3 in non-familial Alzheimer's disease , 2015, Nature.

[43]  A. Hofman,et al.  PLD3 variants in population studies , 2015, Nature.

[44]  J. Hardy,et al.  A Critique of the Drug Discovery and Phase 3 Clinical Programs Targeting the Amyloid Hypothesis for Alzheimer Disease , 2014, Annals of neurology.

[45]  A. Regev,et al.  Preparation of Single‐Cell RNA‐Seq Libraries for Next Generation Sequencing , 2014, Current protocols in molecular biology.

[46]  A. Goate,et al.  Alzheimer’s Disease Genetics: From the Bench to the Clinic , 2014, Neuron.

[47]  S. Itohara,et al.  Single App knock-in mouse models of Alzheimer's disease , 2014, Nature Neuroscience.

[48]  Åsa K. Björklund,et al.  Full-length RNA-seq from single cells using Smart-seq2 , 2014, Nature Protocols.

[49]  S. Gygi,et al.  Identification of a Unique TGF-β Dependent Molecular and Functional Signature in Microglia , 2013, Nature Neuroscience.

[50]  R. Tanzi,et al.  ADAM10 Missense Mutations Potentiate β-Amyloid Accumulation by Impairing Prodomain Chaperone Function , 2013, Neuron.

[51]  Åsa K. Björklund,et al.  Smart-seq2 for sensitive full-length transcriptome profiling in single cells , 2013, Nature Methods.

[52]  Bradley T. Hyman,et al.  Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta , 2013, Neuron.

[53]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[54]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[55]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[56]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[57]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[58]  B. Hyman,et al.  Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.

[59]  B. Strooper,et al.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.

[60]  W. M. van der Flier,et al.  Epidemiology and risk factors of dementia , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[61]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[63]  B. Hyman,et al.  Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APPV717F transgenic mice , 2000, Acta Neuropathologica.

[64]  A. Fagan,et al.  Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[65]  D. Borchelt,et al.  Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins , 1997, Neuron.

[66]  B. Hyman,et al.  Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.

[67]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[68]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[69]  T. Gale,et al.  Sex differences in Alzheimer's disease , 2018, Current opinion in psychiatry.

[70]  J. Hardy,et al.  Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease , 2017, Neurobiology of Aging.

[71]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..